SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000886163-13-000032
Filing Date
2013-04-26
Accepted
2013-04-25 17:56:46
Documents
6
Period of Report
2013-06-11
Effectiveness Date
2013-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A ligand-2013proxystatement.htm DEF 14A 727445
2 attachmenta.jpg GRAPHIC 157401
3 attachmentb.jpg GRAPHIC 158902
4 atachmentc.jpg GRAPHIC 133838
5 attachmentd.jpg GRAPHIC 88766
6 ligandlogo.jpg GRAPHIC 9775
  Complete submission text file 0000886163-13-000032.txt   1485104
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 13784136
SIC: 2834 Pharmaceutical Preparations